ODAC Sides With FDA: Evidence For Elderly AML Drugs Can't Stand On Single-Arm Trials

Feasible or not, randomized controlled trials are needed before approval of Genzyme's Clolar and Vion's Onrigin to treat elderly acute myeloid leukemia patients.